Morningstar

AngioDynamics Inc ANGO

Morningstar Rating

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

Business Wire Oct 3, 2024 10:30am
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

Business Wire Sep 19, 2024 8:40pm
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

Business Wire Sep 19, 2024 12:00pm
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Business Wire Sep 3, 2024 12:30pm
AngioDynamics to Participate in Upcoming Investor Conferences

Business Wire Jul 29, 2024 8:15pm
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

Business Wire Jul 16, 2024 10:30am
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

Business Wire Jul 8, 2024 8:30pm
AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System

Global News Select Apr 4, 2024 2:56pm
AngioDynamics Gets FDA Clearance For Pulmonary Embolism Treatment

Global News Select Apr 4, 2024 11:21am
AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co

Global News Select Apr 1, 2024 10:08pm
AngioDynamics stock dives after sales miss, lowered full-year outlook

MarketWatch Jan 5, 2024 1:13pm

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.